(2S,4R)-4-hydroxy-1-[(2R)-2-[3-[6-[4-[3-(2-hydroxyphenyl)-5-methylthieno[2,3-c]pyridazin-6-yl]piperidin-1-yl]-4-methyl-3-pyridinyl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
C49H52N8O5S2 — CID 177281904
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[6-[4-[3-(2-hydroxyphenyl)-5-methylthieno[2,3-c]pyridazin-6-yl]piperidin-1-yl]-4-methyl-3-pyridinyl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
(2S,4R)-4-hydroxy-1-[(2R)-2-[3-[6-[4-[3-(2-hydroxyphenyl)-5-methylthieno[2,3-c]pyridazin-6-yl]piperidin-1-yl]-4-methyl-3-pyridinyl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide (PubChem CID 177281904) has the molecular formula C49H52N8O5S2 and a molecular weight of 897.14 g/mol. Its IUPAC name is (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[6-[4-[3-(2-hydroxyphenyl)-5-methylthieno[2,3-c]pyridazin-6-yl]piperidin-1-yl]-4-methyl-3-pyridinyl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[6-[4-[3-(2-hydroxyphenyl)-5-methylthieno[2,3-c]pyridazin-6-yl]piperidin-1-yl]-4-methyl-3-pyridinyl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 177281904 |
| Molecular Formula | C49H52N8O5S2 |
| Molecular Weight | 897.14 g/mol |
| Exact Mass | 896.35 |
| IUPAC Name | (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[6-[4-[3-(2-hydroxyphenyl)-5-methylthieno[2,3-c]pyridazin-6-yl]piperidin-1-yl]-4-methyl-3-pyridinyl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
| SMILES | Cc1cc(N2CCC(c3sc4nnc(-c5ccccc5O)cc4c3C)CC2)ncc1-c1cc([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)c2ccc(-c3scnc3C)cc2)C(C)C)on1 |
| InChI | InChI=1S/C49H52N8O5S2/c1-26(2)44(49(61)57-24-34(58)20-40(57)47(60)52-29(5)31-11-13-32(14-12-31)46-30(6)51-25-63-46)42-22-39(55-62-42)37-23-50-43(19-27(37)3)56-17-15-33(16-18-56)45-28(4)36-21-38(53-54-48(36)64-45)35-9-7-8-10-41(35)59/h7-14,19,21-23,25-26,29,33-34,40,44,58-59H,15-18,20,24H2,1-6H3,(H,52,60)/t29-,34+,40-,44+/m0/s1 |
| InChIKey | IHBJYNNRCDRPKQ-KAWDJKCMSA-N |
| XLogP | 9.13 |
| TPSA | 170.70 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 64 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 897.14 |
| LogP ≤ 5 | 9.13 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177281904 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.